Find Topic


Driven by strong market growth, Big Pharma’s interest in China is set to increase

Melbourne, 15th December 2010 – Rapid population growth as well as the increasing number of elderly people in China have created additional pressure on the government in terms of healthcare provision. In order to improve healthcare access, the Chinese government will spend $124.6 billion on healthcare reforms between 2009 and 2011 according to the latest…

15 Dec 2010, by Informa Insights

Transport & Logistics

Informa Interview – Captain Allan Gray on Master Mariners of Australia Congress

[youtube=]   We had the opportunity to interview Captain Allan Gray, Federal Master of the Company of Master Mariners of Australia who will be speaking at the inaugural Master Mariners of Australia Congress on the 7th and 8th April 2011 in Fremantle, WA, Australia. 1. The Company of Master Mariners is hosting its inaugural Master…

6 Dec 2010, by Informa Insights

Transport & Logistics

Informa Interview – Kevin Taylor on thinking outside the square on rail safety

[youtube=] We had the opportunity to interview Kevin Taylor, General Manager of the Rail Industry Safety and Standards Board (RISSB) who will be speaking at the 11th Annual Rail Safety 2011 conference on the 23rd and 24th of March 2011 in Sydney. 1. The theme for RISSB's Rail Safety 2011 is 'Thinking outside the square'.…

6 Dec 2010, by Informa Insights


Smartphones and tablets will aid consumerisation of healthcare in 2011

Melbourne, 6th December 2010. Consumer-driven healthcare will gather momentum in 2011 as the public takes more responsibility for its own health, with technology playing a key role, according to Ovum. In a new report* the independent technology analyst states that devices such as smartphones and tablet computers will help to drive the consumerisation of healthcare…

6 Dec 2010, by Informa Insights

Business | Social Policy

An unashamedly relevant examination of social media’s capacity for revenue generation

We hear about it. We talk about it. We use it everyday. Businesses adopting social media is easy, but doing it right is not. Here's a chance for us to learn how to get it right. [youtube=] The Corporate Social Media Summit 2011 is happening on the 30th-31st March 2011 at the Sydney Harbour Marriott…

1 Dec 2010, by Informa Insights


Disappointing year for Roche but restructuring will help maintain strong fiscal position

Melbourne, 18th November 2010 - John Bird, pharmaceutical company analyst at Datamontior, comments on Roche’s plans to cut 6 percent of its global workforce, or 4800 jobs, over the next two years as part of efforts to make annual cost savings of $2.4 billion: “Many Big Pharma companies have restructured in recent times due to…

18 Nov 2010, by Informa Insights


Market development key for testosterone replacement therapy

Melbourne, 17th November 2010 - Despite growing at a compound annual growth rate of more than 24% over the last five years, the testosterone replacement therapy market is severely underdeveloped. This suggests there are great opportunities for pharmaceutical companies in this field, claims independent market analyst, Datamonitor*. The testosterone replacement therapy market, valued at $838m…

17 Nov 2010, by Informa Insights


Can Pfizer rescue hormonal replacement therapy?

Melbourne, 17th November 2010 - In a market still plagued with safety concerns, Pfizer has an opportunity to restore market growth for hormonal replacement therapy (HRT) with its new combination product, Aprela. To do this it must rebuild public and general practitioner confidence in the therapy area, says independent market analyst, Datamonitor*. The value of…

17 Nov 2010, by Informa Insights


A question of culture as well as structure

IGNORING the entrenched prejudices of further and higher education can lead to divorce. IN 2004, Thames Valley University, a former English polytechnic based in west London, merged with Reading College, a further education institution (or TAFE). The merger was historic, creating England's first dual-sector university. The talk was about providing seamless transition from further to…

1 Nov 2010, by Informa Insights


Pfizer to acquire King Pharmaceuticals for $3.6 billion.

Expert comment from Datamonitor principal analyst Simon King: “The King acquisition represents a small but integral part of a broader diversification strategy that continues to be implemented by Pfizer. This strategy has to date encompassed the multi-billion dollar acquisition of Wyeth but also various in-licensing agreements and a concerted movement into the generics market as…

15 Oct 2010, by Informa Insights
Page  of 137

Get all the latest on Informa news and events

Informa Australia is the nation's leading event organiser. Our events comprise of large scale exhibitions, industry conferences and highly specialised corporate training.

Find out more

Subscribe to Insights

Join Our Newsletter
Informa Insights

Stay up-to-date with all the latest
updates, upcoming events & more.